Ulrike Holzgrabe Selected Research

Ulrike Holzgrabe Research Topics

Disease

10	Infections 01/2024 - 09/2007
7	Alzheimer Disease (Alzheimer's Disease) 03/2023 - 08/2003
5	Neoplasms (Cancer) 02/2024 - 01/2017
3	Hypotension (Low Blood Pressure) 02/2023 - 09/2012
3	Cystic Fibrosis (Mucoviscidosis) 07/2019 - 10/2009
2	African Trypanosomiasis (Nagana) 03/2023 - 05/2018
2	Pain (Aches) 01/2021 - 01/2021
2	Inflammation (Inflammations) 01/2021 - 02/2012
2	Body Weight (Weight, Body) 12/2020 - 06/2019
2	Multiple Myeloma 01/2020 - 01/2017
2	Acquired Immunodeficiency Syndrome (AIDS) 01/2018 - 01/2008
2	Headache (Headaches) 01/2018 - 01/2016
2	Legionnaires' Disease (Legionnaire's Disease) 11/2016 - 01/2011
2	Malaria 01/2008 - 08/2006
1	Chronic Pain 05/2024
1	Communicable Diseases (Infectious Diseases) 01/2022
1	Anaphylaxis (Anaphylactic Shock) 12/2021
1	Leprosy (Hansen's Disease) 09/2021
1	Hyperalgesia 01/2021
1	Schistosomiasis (Bilharziasis) 01/2021
1	Neglected Diseases 01/2021
1	Helminthiasis (Helminthiases) 01/2021
1	Nervous System Diseases (Neurological Disorders) 12/2020
1	Hypertrophy 12/2020
1	Obesity 03/2020
1	Insulin Resistance 03/2020
1	Brain Ischemia (Cerebral Ischemia) 01/2020
1	Hypoxia (Hypoxemia) 01/2020
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2020
1	Squamous Cell Carcinoma of Head and Neck 01/2020
1	Carcinoma (Carcinomatosis) 01/2019
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Uterine Neoplasms (Uterine Cancer) 01/2019
1	Lymphoma (Lymphomas) 03/2018

Drug/Important Bio-Agent (IBA)

4	QuinolonesIBA 03/2023 - 05/2018
3	Cholinergic Agents (Cholinergics)IBA 12/2020 - 02/2007
3	Anti-Bacterial Agents (Antibiotics)IBA 07/2019 - 11/2016
3	Proteins (Proteins, Gene)FDA Link 12/2018 - 01/2011
2	AmidesIBA 03/2023 - 05/2018
2	AntioxidantsIBA 03/2023 - 01/2021
2	Amoxicillin (Wymox)FDA LinkGeneric 01/2017 - 06/2009
2	Clavulanic Acid (Potassium Clavulanate)FDA LinkGeneric 07/2009 - 06/2009
2	Meropenem (Merrem)FDA LinkGeneric 07/2009 - 05/2005
2	LigandsIBA 02/2007 - 08/2003
2	Protease Inhibitors (Protease Inhibitor)IBA 10/2005 - 01/2004
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 05/2024
1	Opioid Receptors (Opioid Receptor)IBA 05/2024
1	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 02/2024
1	Protein Isoforms (Isoforms)IBA 02/2024
1	Lactose FDA LinkGeneric 01/2024
1	CytokinesIBA 01/2024
1	Interleukin-6 (Interleukin 6)IBA 01/2024
1	RNA (Ribonucleic Acid)IBA 01/2024
1	Oxidoreductases (Dehydrogenase)IBA 01/2024
1	Amyloid beta-PeptidesIBA 03/2023
1	Cholinesterases (Cholinesterase)IBA 03/2023
1	AlbuminsIBA 02/2023
1	Pseudoephedrine FDA LinkGeneric 02/2023
1	Ephedrine FDA LinkGeneric 02/2023
1	Histamine (Histamine Dihydrochloride)FDA Link 12/2021
1	Gentamicins (Gentamicin)FDA LinkGeneric 12/2021
1	Rifampin (Rifampicin)FDA LinkGeneric 09/2021
1	Ibuprofen (Motrin)FDA LinkGeneric 01/2021
1	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 01/2021
1	CalciumIBA 01/2021
1	CyclodextrinsIBA 01/2021
1	delphinidinIBA 01/2021
1	Freund's AdjuvantIBA 01/2021
1	AnkyrinsIBA 01/2021
1	Cholinergic ReceptorsIBA 12/2020
1	VanadiumIBA 12/2020
1	Insulin (Novolin)FDA Link 03/2020
1	Glucose (Dextrose)FDA LinkGeneric 03/2020
1	Triglycerides (Triacylglycerol)IBA 03/2020
1	Blood Glucose (Blood Sugar)IBA 03/2020
1	serjanic acidIBA 03/2020
1	CholesterolIBA 03/2020
1	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 01/2020
1	GTP Phosphohydrolases (GTPases)IBA 01/2020
1	Mitogen-Activated Protein KinasesIBA 01/2020
1	isosteviolIBA 01/2020
1	allocryptopineIBA 01/2020
1	Sweetening Agents (Sweeteners)IBA 01/2020
1	ukrainIBA 01/2020
1	SodiumIBA 01/2020
1	chelerythrineIBA 01/2020
1	steviosideIBA 01/2020
1	Neuroprotective AgentsIBA 01/2020
1	PefloxacinIBA 07/2019
1	LactamsIBA 06/2019
1	Estrogen Receptor alphaIBA 01/2019
1	MelatoninIBA 01/2019
1	Tamoxifen FDA LinkGeneric 01/2019
1	Estrogen ReceptorsIBA 01/2019
1	Melatonin Receptors (Melatonin Receptor)IBA 01/2019
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 12/2018
1	FluorineIBA 05/2018
1	Azathioprine (Imuran)FDA LinkGeneric 03/2018

Therapy/Procedure

6	Therapeutics 02/2023 - 05/2007
2	Drug Therapy (Chemotherapy) 03/2012 - 01/2008